Notas
65 KUPISIEWICZ, C.: La escuela y los medios de comunicación
2.1. La radio como medio de comunicación
Many of the effects reported have not been measured over a range of doses, there are only a few clinical studies, very little is known about the
bioavail-ability of most of the compounds and extracts, and the reported effects in vitro may or may not be at relevant doses (i.e., similar to those found in vivo).
Nevertheless, Chinese medicine clearly works in many cases, although the scientific basis of the action and the individual compounds responsible are often not known. In addition, there are a huge range of in vitro tests for anticarcinogenic activity, and it is unlikely that a single one of these tests can predict anticarcinogenicity in vivo, certainly not in humans. It is also possible that separating the active components of CFI may dilute or lose the activity, since synergy and interactions are lost. Another factor is acceptance by the Western medical community and the general public. Clearly CFI are well accepted by many Chinese, and have been used centuries. Perhaps the way forward is to consider how Western and Chinese medicines may complement each other, with conventional drugs for treatment of disease and Chinese medicines for relieving symptoms and treatment of milder complaints where Western medicine is often lacking (with the exception of painkillers).
REFERENCES
1. Song JH, Kim MJ, Kwon HD, Park IH. Antimicrobial activity and components of extracts from Agastache rugosa during growth period. J Food Sci Nutr 2001; 6:10–15.
2. Choi KS, Lee HY. Characteristics of useful components in the leaves of bae-chohyang (Agastache rugosa, O. Kuntze). J Korean Soc Food Sci Nutr 1999;
28:326–332.
3. Lee HK, Oh SR, Kim JI, Kim JW, Lee CO. Agastaquinone, a new cytotoxic diterpenoid quinone from Agastache rugosa. J Nat Products 1995; 58:1718–
1721.
4. Kim JB, Kim JB, Cho KJ, Hwang YS, Park RD. Isolation, identification, and activity of rosmarinic acid, a potent antioxidant extracted from Korean Agastache rugosa. Hanguk Nongwhahak Hoechi 1999; 42:262–266.
5. Swanson LN. Therapeutic value of Aloe vera. US Pharmacist 1995; 20:26–35.
6. Leung AY. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York: John Wiley & Sons, 1980.
7. Blumenthal M. The Complete German Commission E Monographs:
Therapeutic Guide to Herbal Medicine. Austin, TX: American Botanical Council, 1998.
8. Woo SW, Nan JX, Lee SH, Park EJ, Zhao YZ, Sohn DH. Aloe emodin suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Pharmacol Toxicol 2002; 90:193–198.
9. Norikura T, Kennedy DO, Nyarko AF, Kojima A, Matsui YI. Protective effect of aloe extract against the cytotoxicity of 1,4-naphthoquinone in isolated rat hepatocytes involves modulations in cellular thiol levels. Pharmacol Toxicol 2002; 90:278–284.
10. Maze G, Terpolilli RN, Lee M. Aloe vera extract prevents aspirin-induced acute gastric mucosal injury in rats. Med Sci Res 1997; 25:765–766.
11. Teruaki A, Che QM, Kobashi K, Hattori M, Namba T. A purgative action of barbaloin is induced by Eubacterium sp. strain BAR, a human intestinal anaerobe, capable of transforming barbaloin to aloe-emodin anthrone. Biol Pharm Bull 1996; 19:136–138.
12. Lang W. Pharmacokinetic-metabolic studies with14C-aloe emodin after oral administration to male and female rats. Pharmacology 1993; 47:110–119.
13. Yamazaki T, Matsushita Y, Kawashima K, Someya M, Nakajima Y, Kurashige T. Evaluation of the pharmacological activity of extracts from amomi semen on the gastrointestinal tracts. J Ethnopharmacol 2000; 71:331–
335.
14. Sakai K, Miyazaki Y, Yamane T, Saitoh Y, Ikawa C, Nishihata T. Effect of extracts of Zingiberaceae herbs on gastric secretion in rabbits. Chem Pharm Bull 1989; 37:215–217.
15. Okugawa H, Moriyasu M, Saiki K, Kato A, Matsumoto K, Fujioka A, Hashimoto Y. Evaluation of crude drugs by a combination of enfleurage and chromatography. III. Flavour components in seeds of Amomum xanthioides, Alpinia Katsumadai and Amomum Tsao Ko. Shoyakugaku Zasshi 1987;
41:108–115.
16. Yu BY, Mei QC, Wang HM, Wu JJ, Xu GJ. Comparative studies on bioac-tivities of the resources plants of Fructus amoni. J Plant Res Environ 1993;
2:18–21.
17. Iseki K, Ishikawa H, Suzuki T, Murakami T, Otani T, Ishiguro S. Melanosis coli associated with ingestion of bamboo leaf extract. Gastrointest Endosc 1998; 47:305–307.
18. Benavente-Garcia O, Castillo J, del Rio Conesa AJ. Changes in neodiosmin levels during the development of Citrus aurantium leaves and fruits:
postulation of a neodiosmin biosynthetic pathway. J Agric Food Chem 1993; 41:1916–1919.
19. Kim DH, Song MJ, Bae EA, Han MJ. Inhibitory effect of herbal medicines on rotavirus infectivity. Biol Pharm Bull (Jpn) 2000; 23:356–358.
20. Han DI, Hwang BY, Hwang SY, Park JH, Son KH, Lee SH, Chang SY, Kang SJ, Ro JS, Lee KS, Lee KS. Isolation and quantitative analysis of hesperidin from Aurantii fructus. Korean J Pharmacogn 2001; 32:93–97.
21. Lee, et al. Isolation and quantitative analysis of hesperidin from Aurantii fructus. Korean J Pharmacogn 2001; 32:93–97.
22. Matev M, Chakurski I, Stefanov G, Koichev A, Angelov I. Use of an herbal combination with laxative action on duodenal peptic ulcer and gastro-duodenitis patients with a concomitant obstipation syndrome. Vutreshni bolesti (Bulgaria) 1981; 20:48–51.
23. Di Marco MP, Edvards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and seville orange juice on the pharmakinetics of dextro-methorphan: the role of gut CYP3A and P-glycoprotein. Life Sci 2002;
71:1149–1160.
24. Dugo P, Mondello L, Cogliandro E, Verzera A, Dugo G. On the genuineness of citrus essential oils. 51. Oxygen heterocyclic compounds of bitter orange oil (Citrus aurantium L.). J Agric Food Chem 1996; 44:544–549.
25. Miyazawa M, Okuno Y, Fukuyama M, Nakamura S, Kosaka H. Antimuta-genic activity of polymethoxyflavonoids from Citrus aurantium. J Agric Food Chem 1999; 47:5239–5244.
26. Vinson JA, Hu SJ, Jung S, Stanski AM. A citrus extract plus ascorbic acid de-creases lipids, lipid peroxides, lipoprotein oxidative susceptibility, and athe-rosclerosis in hypercholesterolemic hamsters. J Agric Food Chem 1998; 46:
1453–1459.
27. Carnat A, Carnat AP, Fraisse D, Lamaison JL. Note technique. Standard-isation de la fleur et de la feuille d’oranger amer. Ann Pharm Fr 1999; 57:410–
414.
28. Colker CM, Kalman D, Torina GC, Perlis T, Street C. Effects of Citrus aurantiumextract, caffeine, and St. John’s wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr Ther Res 1999; 60:145–
153.
29. Calapai G, Firenzuoli F, Saitta A, Squadrito F, Arlotta MR, Costantino G, Inferrera G. Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report. Fitoterapia 1999; 70:586–592.
30. Calvarano I. Contributo all’indagine analitica strumentale dell’essenza di arancio amaro. Essenz Deriv Agrum 1966; 36:5–25.
31. Chidume FC, Kwanashie HO, Adekeye JO, Wambebe C, Gamaniel KS.
Antinociceptive and smooth muscle contracting activities of the methanolic extract of Cassia tora leaf. J Ethnopharmacol 2002; 81:205–209.
32. Yen GC, Chen HW, Duh PD. Extraction and identification of an antioxidative component from jue ming zi (Cassia tora L.). J Agric Food Chem 1998;
46:820–824.
33. Vadivel V, Janardhanan K. Agrobotanical traits and chemical composition of Cassia obtusifoliaL.: a lesser-known legume of the Western Ghats region of South India. Plant Foods Hum Nutr 2002; 57:151–164.
34. Voss KA, Brennecke LH. Toxicological and hematological effects of sicklepod (Cassia obtusifolia) seeds in Sprague-Dawley rats: a subchronic feeding study.
Official J Int Soc Toxicol 1991; 29:1329–1336.
35. Pool-Zobel B, van Loo J, Rowland I, Roberfroid MB. Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br J Nutr 2002; 87:273–281.
36. Kim MH. The water-soluble extract of chicory reduces cholesterol uptake in gut-perfused rats. Nutr Res 2000; 20:1017–1026.
37. Kim MH, Shin HK. The water-soluble extract of chicory reduces glucose uptake from the perfused jejunum in rats. J Nutr 1996; 126:2236–2242.
38. Hond ED, Geypens B, Ghoos Y. Effect of high performance chicory inulin on constipation. Nutr Res 2000; 20:731–736.
39. Russell TJ. The effect of natural source of non-digestible oligosaccharides on the fecal microflora of the dog and effects on digestion. Friskies PetCare 1998;
19.
40. Zhang W, Jia W, Li S, Zhang J, Qu Y, Xu X. Chinese Medicated Diet.
Shanghai, China: Publishing House of Shanghai College of Traditional Chinese Medicine, 1988.
41. Wang SG, Wu XZ. Analysis of nutrient components of Chinese yam in Anshun of Guizhou Province. J Mountain Agric Biol 2001; 20:191–195.
42. Hang YY, Qin HZ, Ding ZZ. A survey and quality research on the new resources of Shan Yao (Rhizoma dioscoreae). J Plant Resources Environ 1992;
1:10–15.
43. China Pharmacopoea (State Pharmarcopoea Committee Eds) Chemical In-dustry Publishing House, Beijing 2000.
44. Wang HK, Xia Y, Yang ZY, Natschke SL, Lee KH. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv Exp Med Biol 1998; 439:191–225.
45. Hu CQ, Chen K. Anti-AIDS agents, Acacetin-7-O-h-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids. J Nat Prod 1994; 57:42–51.
46. Lee HS, Ahn YJ. Growth-inhibiting effects of Cinnamomum cassia bark-derived materials on human intestinal bacteria. J Agric Food Chem 1998;
46:8–12.
47. Zhu ZP, Zhang MF, Shen YQ, Chen GJ. Pharmacological study on spleen-stomach warming and analgesic action of Cinnamomum cassia. Presl China J Chinese Mater Med 1993; 18:553–557.
48. Kwon BM, Cho YK, Lee SH, Nam JY, Bok SH, Chun SK, Kim JA, Lee IR.
2V-Hydroxycinnamaldehyde from stem bark of Cinnamomum cassia. Planta Med 1996; 62:183–184.
49. Zheng GQ, Kenney PM, Lam LK. Sesquiterpenes from clove (Eugenia caryo-phyllata) as potential anticarcinogenic agents. J Nat Prod 1992; 55:999–1003.
50. Vijayalakshmi R, Quadri SSYH, Deosthale YG. Effect of eugenol on gastric function in rats. J Clin Biochem Nutr 1991; 10:161–170.
51. Toda M, Kawabata J, Kasai T. Inhibitory effects of ellagi- and gallotannins on rat intestinal a-glucosidase complexes. Biosci Biotechnol Biochem 2001; 65:
542–547.
52. Toda M, Kawabata J, Kasai T. a-Glucosidase inhibitors from clove (Syzgium aromaticum). Biosci Biotechnol Biochem 2000; 64:294–298.
53. Kreydiyyeh SI, Usta J, Copti R. Effect of cinnamon, clove and some of their constituents on the Na+-K+-ATPase activity and alanine absorption in the rat jejunum. Food Chem Toxicol 2000; 38:755–762.
54. Platel K, Srinivasan K. A study of the digestive stimulant action of select spices in experimental rats. J Food Sci Technol (Mysore) 2001; 38:358–361.
55. Platel, Srinivasan. Stimulatory influence of select spices on bile secretion in rats. Nutr Res 2000; 20:1493–1503.
56. Micklefield GH, Redeker Y, Meister V, Jung O, Greving I, May B. Effects of ginger on gastroduodenal motility. Int J Clin Pharmacol Ther 1999; 37:341–
346.
57. Surh YJ. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999; 428:305–327.
58. Haslam E. Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J Nat Prod 1996; 59:205–215.
59. Suleyman H, Demirezer LO, Buyukokuroglu ME, Akcay MF, Gepdiremen A, Banoglu ZN, Gocer F. Antiulcerogenic effect of Hippophae rhamnoides L.
Phytother Res 2001; 15:625–627.
60. Cheng TJ, Sai Ram M, Singh V, Ilavazhagan G, Sawhney RC. Protective action of seed oil of Hippophae rhamnoides L. (HR) against experimental liver injury in mice. Zhonghua Yu Fang Yi Xue Za Zhi 1992; 26:227–229.
61. Wang Y, Lu Y, Liu X, Gou Z, Hu J. The protective effect of Hippophae rhamnoidesL. on hyperlipidemic serum cultured smooth muscle cells in vitro.
Zhongguo Zhong Yao Za Zhi 1992; 17:624–626.
62. Geetha S, Sai Ram M, Singh V, Ilavazhagan G, Sawhney RC. Anti-oxidant and immunomodulatory properties of seabuckthorn (Hippophae rhamnoides)–
an in vitro study. J Ethnopharmacol 2002; 79:373–378.
63. Goel HC, Prasad J, Singh S, Sagar RK, Kumar IP, Sinha AK. Radio-protection by a herbal preparation of Hippophae rhamnoides, RH-3, against whole body lethal irradiation in mice. Phytomedicine 2002; 9:15–25.
64. Kumar IP, Namita S, Goel HC. Modulation of chromatin organization by RH-3, a preparation of Hippophae rhamnoides, a possible role in radiopro-tection. Mol Cell Biochem 238:1–9.
65. Yu XY. Blockage of Glyrrhiza uralensis and Chelidonium majus in MNNG induced cancer and mutagenesis. Zhonghua Yu Fang Yi Xue Za Zhi 1992; 26:
165–167.
66. Chen XG, Han R. Effect of glycyrrhetinic acid on DNA damage and un-scheduled DNA synthesis induced by benzo (a) pyrene. Yao Xue Xue Bao 1994; 29:725–729.
67. Fu N, Liu Z, Zhang R. Anti-promoting and anti-mutagenic actions of G9315.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1995; 17:349–352.
68. Ma J, Peng W, Liang D. Apoptosis of human gastric cancer cell line MGC-803 induced by Glycyrrhiza uralensis extract. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000; 20:928–930.
69. Ma J, Fu NY, Pang DB, Wu WY, Xu AL. Apoptosis induced by isoli-quiritigenin in human gastric cancer MGC-803 cells. Planta Med 2001; 67:754–
757.
70. Yu XY. A prospective clinical study on reversion of 200 precancerous patients with hua-sheng-ping. Zhongguo Zhong Xi Yi Jie He Za Zhi 1993; 13:147–149.
71. Wang ZY, Nixon DW. Licorice and cancer. Nutr Cancer 2001; 39:1–11.
72. Onogi N, Okuno M, Komaki C, Moriwaki H, Kawamori T, Tanaka T, Mori H, Muto Y. Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats. Carcinogenesis 1996; 17:1291–1296.
73. Narisawa T, Fukaura Y, Yazawa K, Ishikawa C, Isoda Y, Nishizawa Y.
Colon cancer prevention with a small amount of dietary perilla oil high in alpha-linolenic acid in an animal model. Cancer 1994; 73:2069–2075.
74. Narisawa T, Takahashi M, Kotanagi H, Kusaka H, Yamazaki Y, Koyama H, Fukaura Y, Nishizawa Y, Kotsugai M, Isoda Y. Inhibitory effect of dietary
perilla oil rich in the n-3 polyunsaturated fatty acid a-linolenic acid on colon carcinogenesis in rats. Jpn J Cancer Res 1991; 82:1089–1096.
75. Xia Q, Xiao P, Wan L, Kong J. Ethnopharmacology of Phyllanthus emblica L.
Zhongguo Zhong Yao Za Zhi 1997; 22:515–518.
76. Dhir H, Agarwal K, Sharma A, Talukder G. Modifying role of Phyllanthus emblicaand ascorbic acid against nickel clastogenicity in mice. Cancer Lett 1991; 59:9–18.
77. Jeena KJ, Joy KL, Kuttan R. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcino-genesis. Cancer Lett 1999; 136:11–16.
78. Suresh K, Vasudevan DM. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. J Ethnopharmacol 1994; 44:55–60.
79. Ukiya M, Akihisa T, Tokuda H, Hirano M, Oshikubo M, Nobukuni Y, Kimura Y, Tai T, Kondo S, Nishino H. Inhibition of tumor-promoting effects by poricoic acids G and Hand other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G from Poria cocos. J Nat Prod 2002; 65:462–
465.
80. Kaminaga T, Yasukawa K, Kanno H, Tai T, Nunoura Y, Takido M.
Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 1996; 53:382–385.
81. Yu SJ, Tseng J. Fu-Ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes. Int J Immunopharmacol 1996; 18:37–
44.
82. Kanayama H, Togami M, Adachi N, Fukai Y, Okumoto T. Studies on the antitumor active polysaccharides from the mycelia of Poria cocos Wolf. III.
Antitumor activity against mouse tumors. Yakugaku Zasshi 1986; 106:307–
312.
83. Sakamoto S, Kudo H, Kuwa K, Suzuki S, Kato T, Kawasaki T, Nakayama T, Kasahara N, Okamoto R. Anticancer effects of a Chinese herbal medicine, juzen-taiho-to, in combination with or without 5-fluorouracil derivative on DNA-synthesizing enzymes in 1,2-dimethylhydrazine induced colonic cancer in rats. Am J Chinese Med 1991; 19:233–241.
84. Wu Y, Zhang Y, Wu JA, Lowell T, Gu M, Yuan CS. Effects of Erkang, a modified formulation of Chinese folk medicine Shi-Quan-Da-Bu-Tang, on mice. J Ethnopharmacol 1998; 61:153–159.
85. Zee-Cheng RK. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT: a potent Chinese biological response modifier in cancer immunotherapy, poten-tiation and detoxification of anticancer drugs. Methods Find Exp Clin Phar-macol 1992; 14:725–736.
86. Park JH, Cho CH, Yun SJ. Microscopic identification of Jeong Dan Whan.
Ko- rean J Pharmacognosy 2002; 33:53–56.
87. Li GP, Huang CH. Effects of Chinese medical herbs on controlling piglet early weaning diarrhoea. Chinese J Vet Sci 2002; 22:65–67.
88. Kang JK, Bae HS, Kim YS, Cho KH, Lee KS, Park EK, Kim DH. Anti-thrombosis of Chungpesagan-tang is activated by human intestinal bacteria.
Nat Prod Sci 2001; 7:53–59.
89. Sheu SJ, Lu CF. Determination of six bioactive components of hsiao-cheng-chi-tang by capillary electrophoresis. J High Resolut Chromatogr 1995;
18:269–270.
90. Walle UK, Walle T. Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids—structural requirements. Drug Metab Dispos 2002;
30:564–569.
91. Doostdar H, Burke MD, Mayer RT. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000;
144:31–38.
92. Kawai S, Tomono Y, Katase E, Ogawa K, Yano M. Effect of citrus flavonoids on HL-60 cell differentiation. Anticancer Res 1999; 19:1261–1269.
93. Boege F, Straub T, Kehr A, Boesenberg C, Christiansen K, Andersen A, et al.
Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J Biol Chem 1996; 271:2262–2270.
94. Chae YH, Ho DK, Cassady JM, Cook VM, Marcus CB, Baird WM. Effects of synthetic and naturally occurring flavonoids on metabolic activation of benzo[a]pyrene in hamster embryo cell cultures. Chem Biol Interact 1992; 82:
181–193.
95. Lee C, Kim H, Kho Y. Agastinol and agastenol, novel lignans from Agastache rugosaand their evaluation in an apoptosis inhibition assay. J Nat Prod 2002;
65:414–416.
96. Ghelardini C, Galeotti N, Mazzanti G. Local anaesthetic activity of mono-terpenes and phenylpropanes of essential oils. Planta Med 2001; 67:564–566.
97. De M, De AK, Sen P, Banerjee AB. Antimicrobial properties of star anise (Illicium verum Hook f ). Phytother Res 2002; 16:94–95.
98. Abraham SK. Anti-genotoxicity of trans-anethole and eugenol in mice. Food Chem Toxicol 2001; 39:493–498.
99. Chainy GB, Manna SK, Chaturvedi MM, Aggarwal BB. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor:
effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene 2000;
19:2943–2950.
100. Rompelberg CJ, Verhagen H, van Bladeren PJ. Effects of the naturally oc-curring alkenylbenzenes eugenol and trans- anethole on drug-metabolizing enzymes in the rat liver 76. Food Chem Toxicol 1993; 31:637–645.
101. Shafi PM, Rosamma MK, Jamil K, Reddy PS. Antibacterial activity of the es-sential oil from Aristolochia indica. Fitoterapia 2002; 73:439–441.
102. Tambe Y, Tsujiuchi H, Honda G, Ikeshiro Y, Tanaka S. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene. Plan- ta Med 1996; 62:469–470.
103. Kubo I, Chaudhuri SK, Kubo Y, Sanchez Y, Ogura T, Saito T, et al. Cytotoxic and antioxidative sesquiterpenoids from Heterotheca inuloides. Planta Med 1996; 62:427–430.
104. Mori H, Kawabata K, Matsunaga K, Ushida J, Fujii K, Hara A, et al.
Chemopreventive effects of coffee bean and rice constituents on colorectal carcinogenesis. Biofactors 2000; 12:101–105.
105. Agarwal SK, Singh SS, Verma S, Kumar S. Antifungal activity of anthra-quinone derivatives from Rheum emodi. J Ethnopharmacol 2000; 72:43–46.
106. Sun MZ, Sakakibara H, Ashida H, Danno G, Kanazawa K. Cytochrome P4501A1—inhibitory action of antimutagenic anthraquinones in medicinal plants and the structure-activity relationship. Biosci Biotechnol Biochem 2000;
64:1373–1378.
107. Kim DH, Park EK, Bae EA, Han MJ. Metabolism of rhaponticin and chry-sophanol 8-o-h-D-glucopyranoside from the rhizome of Rheum undulatum by human intestinal bacteria and their anti-allergic actions. Biol Pharm Bull 2000;
23:830–833.
108. Friedman M, Henika PR, Mandrell RE. Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. J Food Protect 2002; 65:1545–1560.
109. Koh WS, Yoon SY, Kwon BM, Jeong TC, Nam KS, Han MY.
Cinnamaldehyde inhibits lymphocyte proliferation and modulates T-cell differentiation. Int J Immunopharmacol 1998; 20:643–660.
110. Chang CH, Lin CC, Yang JJ, Namba T, Hattori M. Anti-inflammatory effects of emodin from ventilago leiocarpa. Am J Chinese Med 1996; 24:139–142.
111. Lang W. Pharmacokinetic-metabolic studies with 14C-aloe emodin after oral administration to male and female rats. Pharmacology 1993; 47:110–119.
112. Su HY, Cherng SH, Chen CC, Lee H. Emodin inhibits the mutagenicity and DNA adducts induced by 1- nitropyrene. Mutat Res 1995; 329:205–212.
113. Zhang L, Lau YK, Xi L, Hong RL, Kim DS, Chen CF, et al. Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu- induced cellular transformation and metastasis-associated properties. Oncogene 1998; 16:2855–2863.
114. Kumar A, Dhawan S, Aggarwal BB. Emodin (3-methyl-1,6,8-trihydroxyan-thraquinone) inhibits TNF-induced NF- kappaB activation, lkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 1998; 17:913–918.
114a. Yim H, Lee YH, Lee CH, Lee SK. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor. Planta Med 1999; 65:9–13.
115. Lee JJ, Park KH, Yu HG, Lee J, Kang SG, Yoo YD, et al. Antiproliferative effect of 2V-benzoxy-cinnamaldehyde on cultured human retinal pigment epi-thelial cells in vitro and safety of intravitreal 2V-benzoxy-cinnamaldehyde on rabbit eyes in vivo. Invest Ophthalmol Vis Sci 2001; 42:4351.
116. Wang HW, Chen TL, Yang PC, Ueng TH. Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5. Drug Metab Dispos 2001; 29:1229–1235.
117. Cheng YW, Kang JJ. Emodin-induced muscle contraction of mouse
diaphragm and the involvement of Ca2+ influx and Ca2+ release from sarcoplasmic reticulum. Br J Pharmacol 1998; 123:815–820.
118. Chung DC. The genetic basis of colorectal cancer: insights into critical path-ways of tumorigenesis. Gastroenterology 2000; 119:854–865.
119. Ishiwata S, Nakashita K, Ozawa Y, Niizeki M, Nozaki S, Tomioka Y, et al.
Fas-mediated apoptosis is enhanced by glycyrrhizin without alteration of cas-pase-3-like activity. Biol Pharm Bull 1999; 22:1163–1166.
120. Tanaka T, Kohno H, Murakami M, Shimada R, Kagami S, Sumida T, et al.
Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in beta-cryptoxanthin and hesperidin. Int J Cancer 2000; 88:146–150.
121. Koyuncu H, Berkarda B, Baykut F, Soybir G, Alatli C, Gul H, et al. Preventive effect of hesperidin against inflammation in CD-1 mouse skin caused by tumor promoter. Anticancer Res 1999; 19:3237–3241.
122. Yang MZ, Tanaka T, H irose Y, Deguchi T, Mori H , Kawada Y.
Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male icr mice. Int J Cancer 1997; 73:719–724.
123. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, et al.
Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis 1997; 18:761–769.
124. Bouaziz N, Michiels C, Janssens D, Berna N, Eliaers F, Panconi E, et al. Effect of Ruscus extract and hesperidin methylchalcone on hypoxia-induced
124. Bouaziz N, Michiels C, Janssens D, Berna N, Eliaers F, Panconi E, et al. Effect of Ruscus extract and hesperidin methylchalcone on hypoxia-induced